These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 116484)

  • 1. Diabetic glomerulopathy: a dynamic process produced by the diabetic environment.
    Steffes MW; Brown DM; Mauer SM
    Adv Exp Med Biol; 1979; 124():157-66. PubMed ID: 116484
    [No Abstract]   [Full Text] [Related]  

  • 2. The development, enhancement and reversibility of diabetic glomerulopathy.
    Steffes MW; Brown DM; Mauer SM
    Adv Exp Med Biol; 1979; 119():473-8. PubMed ID: 115236
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for the influence of euglycemia on diabetic microangiopathy.
    Federlin K; Bretzel RG; Manns E
    Horm Metab Res Suppl; 1979; (8):8-15. PubMed ID: 119700
    [No Abstract]   [Full Text] [Related]  

  • 4. Amelioration of mesangial volume and surface alterations following islet transplantation in diabetic rats.
    Steffes MW; Brown DM; Basgen JM; Mauer SM
    Diabetes; 1980 Jul; 29(7):509-15. PubMed ID: 6769731
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of diabetic glomerulopathy in streptozotocin diabetic rats by insulin treatment. The mesangial regions.
    Rasch R
    Diabetologia; 1979 Oct; 17(4):243-8. PubMed ID: 499683
    [No Abstract]   [Full Text] [Related]  

  • 6. Animal models of diabetic nephropathy.
    Mauer SM; Steffes MW; Brown DM
    Adv Nephrol Necker Hosp; 1979; 8():23-42. PubMed ID: 115242
    [No Abstract]   [Full Text] [Related]  

  • 7. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy.
    Fujihara CK; Padilha RM; Zatz R
    Diabetes; 1992 Mar; 41(3):286-93. PubMed ID: 1551488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet transplantation in experimental diabetes of the rat. VI. Rate of regression in diabetic kidney lesions after isogeneic islet transplantation: quantitative measurements.
    Bretzel RG; Breidenbach C; Hofmann J; Federlin K
    Horm Metab Res; 1979 Mar; 11(3):200-7. PubMed ID: 109383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes. Reversion of diabetic kidney lesions by islands of Langerhans transplantation in rats. Quantitative morphology].
    Bretzel RG; Federlin K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1373-7. PubMed ID: 417493
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenesis of diabetic glomerulopathy: hemodynamic considerations.
    Hostetter TH
    Semin Nephrol; 1990 May; 10(3):219-27. PubMed ID: 2190279
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetic glomerulopathy following unilateral nephrectomy in the rat.
    Steffes MW; Brown DM; Mauer SM
    Diabetes; 1978 Jan; 27(1):35-41. PubMed ID: 340310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical characterization of glomerular PDGF B-chain and PDGF beta-receptor expression in diabetic rats.
    Nakagawa H; Sasahara M; Haneda M; Koya D; Hazama F; Kikkawa R
    Diabetes Res Clin Pract; 2000 May; 48(2):87-98. PubMed ID: 10802145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy.
    Zatz R; Meyer TW; Rennke HG; Brenner BM
    Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5963-7. PubMed ID: 3862110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glomerular barrier dysfunction in glomerulosclerosis- resistant Milan rats with experimental diabetes: the role of renal haemodynamics.
    Pugliese G; Ricci C; Iacobini C; Menini S; Fioretto P; Ferrandi M; Giardino LA; Armelloni S; Mattinzoli D; Rastaldi MP; Pugliese F
    J Pathol; 2007 Oct; 213(2):210-8. PubMed ID: 17768702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early, but not advanced, glomerulopathy is reversed by pancreatic islet transplants in experimental diabetic rats: correlation with glomerular extracellular matrix mRNA levels.
    Pugliese G; Pricci F; Pesce C; Romeo G; Lenti E; Caltabiano V; Vetri M; Purrello F; Di Mario U
    Diabetes; 1997 Jul; 46(7):1198-206. PubMed ID: 9200656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular basement membrane thickness following islet transplantation in the diabetic rat.
    Steffes MW; Brown DM; Basgen JM; Matas AJ; Mauer SM
    Lab Invest; 1979 Aug; 41(2):116-8. PubMed ID: 110982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic glomerulopathy in the uninephrectomized rat resists amelioration following islet transplantation.
    Steffes MW; Vernier RL; Brown DM; Basgen JM; Mauer SM
    Diabetologia; 1982 Oct; 23(4):347-53. PubMed ID: 6814977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet transplantation restores the damage of glomerulus filtration membrane in a rat model of streptozotocin-induced diabetic nephropathy.
    Ziqiang X; Yunqiang H; Hongxing F; Jinjun W; Yong C
    J Pak Med Assoc; 2016 Mar; 66(3):296-301. PubMed ID: 26968280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic nephropathy: can the natural history be modified?
    Narins RG
    Am J Med; 1991 Feb; 90(2A):70S-75S. PubMed ID: 1994723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats.
    O'Donnell MP; Kasiske BL; Daniels FX; Keane WF
    Diabetes; 1986 Sep; 35(9):1011-5. PubMed ID: 3743905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.